Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo

Biochimica et Biophysica Acta - Biomembranes

Volumn 1466, Issue 1-2, 2000, Pages 205-220

  Lopes De Menezes, Daniel E ^a   Pilarski, Linda M ^a   Belch, Andrew R ^a   Allen, Theresa M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

CD19; Doxorubicin; Liposome; Multiple myeloma; Targeted drug delivery

Indexed keywords

CD19 ANTIGEN; DOXORUBICIN; IMMUNOLIPOSOME;

ARTICLE; B LYMPHOCYTE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; INTERNALIZATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CYTOTOXICITY, IMMUNOLOGIC; DOXORUBICIN; DRUG CARRIERS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; MICE; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED;

EID: 0034214039     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(00)00203-0     Document Type: Article

References (66)

1. Griepp P.R. Semin. Hematol. 29:1992;24-45.
2. Osserman E.F., Giampaolo M., Butler V.P. J. Am. Med. Assoc. 258:1987;2930-2937.
3. Barlogie B., Gahrton G. Bone Marrow Transplant. 7:1991;71-79.
4. Szczepek A.J., Bergsagel P.L., Axelsson L., Brown C.B., Belch A.R., Pilarski L.M. Blood. 89:1997;1824-1833.
5. Pilarski L.M., Szczepek A.J., Belch A.R. Blood. 90:1997;3751-3759.
6. Szczepek A.J., Seeberger K., Wizniak J., Mant M.J., Belch A.R., Pilarski L.M. Blood. 90:1998;2844-2855.
7. Pilarski L.M., Masellis-Smith A., Szczepek A., Mant M.J., Belch A.R. Leuk. Lymphoma. 18:1995;179-187.
8. Pilarski L.M., Jensen G.S. Hematol. Oncol. Clin. North Am. 6:1992;297-322.
9. Jensen G.S., Belch A.R., Mant M.J., Ruether B.A., Yacyshyn B.R., Pilarski L.M. Am. J. Hematol. 43:1992;29-39.
10. Jensen G.S., Mant M.J., Belch A.R., Berensen J.R., Ruether B.A., Pilarski L.M. Blood. 78:1991;711-719.
11. Masellis-Smith A., Belch A.R., Mant M.J., Pilarski L.M. Cancer Res. 57:1997;930-936.
12. Pilarski L.M., Cass C.E., Tsuro T., Belch A.R. Curr. Top. Microbiol. Immunol. 182:1992;177-185.
13. Pilarski L.M., Belch A.R. Blood. 83:1994;724-736.
14. Pilarski L.M., Belch A.R. Leuk. Lymphoma. 17:1995;367-374.
15. Grogan T.M., Spier C.M., Salmon S.E., Matzner M., Rybski J., Weinstein R.S., Scheper R.J., Dalton W.S. Blood. 81:1993;490-495.
16. van Oosterhout Y.V.J.M., van den Herik-Oudijk I.E., Wessels H.M.C., de Witte T., van de Winkel J.G.J., Preijers F.W.M.B. Cancer Res. 54:1994;3527-3532.
17. Uckun F.M., Jaszcz W., Ambrus J.L., Fauci A.S., Gajl-Peczalska K., Song S.W., Wick M.R., Myers D.E., Waddick K., Ledbetter J.A. Blood. 71:1988;13-29.
18. Nicholson I.C., Lenton K.A., Little D.J., DeCorso T., Lee F.T., Scott A.M., Zola H., Hohmann A.W. Mol. Immunol. 34:1998;1157-1165.
19. de Rie M.A., Schumacher T.N., van Schijndel G.M., van Lier R.A., Miedema F. Cell. Immunol. 118:1989;368-381.
20. Press O.W., Farr A.G., Borroz K.I., Andersen S.K., Martin P.J. Cancer Res. 49:1989;4906-4912.
21. Ghetie M.A., Picker L.J., Richardson J.A., Tucker K., Uhr J.W., Vitetta E.S. Blood. 83:1994;1329-1336.
22. Pizer B.L., Kemshead J.T. Leuk. Lymphoma. 15:1994;281-289.
23. Vervoordeldonk S.F., Merle P.A., van Leeuwen E.F., von dem Borne A.E., Slaper-Cortenbach I.C. Cancer. 73:1994;1006-1011.
24. Stone M.J., Sausville E.A., Fay J.W., Headlee D., Collins R.H., Figg W.D., Stetler Stevenson M., Jain V., Jaffe E.S., Solomon D., Lush R.M., Senderowicz A., Ghetie V., Schindler J., Uhr J.W., Vitetta E.S. Blood. 88:1996;1188-1197.
25. Hekman A., Honselaar A., Vuist W.M., Sein J.J., Rodenhuis S., Bokkel Huinink W.W., Somers R., Rumke P., Melief C.J. Cancer Immunol. Immunother. 32:1991;364-372.
26. Grossbard M.L., Freedman A.S., Ritz J., Coral F., Goldmacher V.S., Eliseo L., Spector N., Dear K., Lambert J.M., Blattler W.A., Taylor J.A., Nadler L.M. Blood. 79:1992;576-585.
27. Allen T.M., Ahmad I., Lopes de Menezes D.E., Moase E.H. Biochem. Soc. Trans. 23:1995;1073-1079.
28. Vingerhoeds M.H., Storm G., Crommelin D.J. Immunomethods. 4:1994;259-272.
29. Park J.W., Hong K., Kirpotin D.B., Papahadjopoulos D., Benz C.C. Adv. Pharmacol. 40:1997;399-435.
30. Ahmad I., Longenecker M., Samuel J., Allen T.M. Cancer Res. 53:1993;1484-1488.
31. Mori A., Kennel S.I., Waalkes M.V.B., Scherphof G.L., Huang L. Cancer Chemother. Pharmacol. 35:1995;447-456.
32. Lopes de Menezes D.E., Pilarski L.M., Allen T.M. Cancer Res. 58:1998;3320-3330.
33. Lang J., Vigo-Pelfrey C., Martin F. Chem. Phys. Lipids. 53:1990;91-101.
34. Allen T.M., Hansen C.B., Martin F., Redemann C., Yau-Young A. Biochim. Biophys. Acta. 1066:1991;29-36.
35. Zalipsky S. Bioconjug. Chem. 4:1993;296-299.
36. Zola H., Macardle P.J., Bradford T., Weedon H., Yasui H., Kurosawa Y. Immunol. Cell Biol. 69:1991;411-422.
37. Pool G.L., French M.E., Edwards R.A., Huang L., Lumb R.H. Lipids. 17:1982;445-452.
38. Derksen J.T., Morselt H.W., Scherphof G.L. Biochim. Biophys. Acta. 931:1987;33-40.
39. Mayer L.D., Hope M.J., Cullis P.R. Biochim. Biophys. Acta. 858:1986;161-168.
40. Bartlett G.R. J. Biol. Chem. 234:1959;466-468.
41. D.D. Lasic, Liposomes: from Physics to Applications, Elsevier Science Publishers, Amsterdam, 1993.
42. Bolotin E.M., Cohen R., Bar L.K., Emanuel S.N., Lasic D.D., Barenholz Y. J. Liposome Res. 4:1994;455-479.
43. Hansen C.B., Kao G.Y., Moase E.H., Zalipsky S., Allen T.M. Biochim. Biophys. Acta. 1239:1995;133-144.
44. Daleke D.L., Hong K., Papahadjopoulos D. Biochim. Biophys. Acta. 1024:1990;352-366.
45. Straubinger R.M., Papahadjopoulos D., Hong K. Biochemistry. 29:1990;4929-4939.
46. Mosmann T. J. Immunol. Methods. 65:1983;55-63.
47. Coleman A.W., Maguire M.J., Coleman J.R. J. Histochem. Cytochem. 29:1981;959-968.
48. Hedley D.W., Friedlander M.L., Taylor I.W. Cytometry. 6:1985;327-333.
49. Goulet A.C., Goldmacher V.S., Lambert J.M., Baron C., Roy D.C., Kouassi E. Blood. 90:1997;2364-2375.
50. Lambert J.M., Goldmacher V.S., Collinson A.R., Nadler L.M., Blattler W.A. Cancer Res. 51:1991;6236-6242.
51. T.M. Allen, D. Stuart, in: A.S. Janoff (Ed.), Liposomes: Rational Design, Marcel Dekker, New York, 1998, pp. 63-97.
52. Vitetta E.S., Uhr J.W. Cancer Res. 54:1994;5301-5309.
53. Bruggemann M., Williams G.T., Bindon C.I., Clark M.K., Walker M.R., Jefferis R., Waldmann H., Neugerger M.S. J. Exp. Med. 166:1987;127-142.
54. Steplewski Z., Sun L.K., Shearman C.W., Ghrayeb J., Daddona P., Koprowski H. Proc. Natl. Acad. Sci. USA. 85:1988;4852-4856.
55. Gianni L., Corden B., Myers C. Rev. Biochem. Toxicol. 5:1983;1-82.
56. Northfelt D.W., Martin F.J., Kaplan L.D., Russell J., Andersen M., Lang J., Volberding P.A. Proc. Am. Soc. Clin. Oncol. 12:1993;A8.
57. Gottesman M.M. Cancer Res. 53:1993;747-754.
58. Bradley G., Ling V. Cancer Metastasis Rev. 13:1994;223-233.
59. Sumizawa T., Chuman Y., Sakamoto H., Iemura K., Almquist K.C., Deeley R.G., Cole S.P., Akiyama S. Somat. Cell Mol. Genet. 20:1994;423-435.
60. Lee R.J., Low P.S. J. Biol. Chem. 269:1994;3198-3204.
61. Kirpotin D., Park J.W., Hong K., Zalipsky S., Li W.-L., Carter P., Benz C.C., Papahadjopoulos D. Biochemistry. 36:1997;66-75.
62. Lopes de Menezes D.E., Kirchmeier M.J., Gagne J.-F., Pilarski L.M., Allen T.M. J. Liposome Res. 9:1999;199-228.
63. Bergsagel D.E. Ann. Rev. Med. 30:1979;431-433.
64. T.M. Allen, C.B. Hansen, D.D. Stuart, in: D.D. Lasic, D. Papahadjopoulos (Eds.), Medical Applications of Liposomes, Elsevier Science Publishers, Amsterdam, 1998, pp. 297-323.
65. Kaminski M.S., Zasadny K.R., Francis I.R., Milik A.W., Ross C.W., Moon S.D., Crawford S.M., Burgess J.M., Petry N.A., Butchko G.M., Glenn S.D., Wahl R.L. N. Engl. J. Med. 329:1993;459-465.
66. Vitetta E.S., Stone E., Amlot P., Fay J., May R., Till M., Newman J., Clark P., Collins R., Cunningham D., Ghetie V., Uhr J.W., Thorpe P.E. Cancer Res. 51:1991;4052.